9 results on '"Tardio M.L."'
Search Results
2. T.12.10: BIOPSIES SAMPLING IN HELICOBACTER PYLORI NEGATIVE PATIENTS: IS IT STILLWORTHY?
- Author
-
Fiorini, G., primary, Pavoni, M., additional, D'Errico, A., additional, Tardio, M.L., additional, Saracino, I.M., additional, Zullo, A., additional, Massarenti, G., additional, Arlotti, L., additional, Borghi, C., additional, and Vaira, B., additional
- Published
- 2024
- Full Text
- View/download PDF
3. OP-190 RECOVERY OF A FULMINANT MYOCARDITIS TREATED WITH ECMO AND IMPELLA
- Author
-
Amarelli, C., primary, Marra, C., additional, Romano, G., additional, Verniero, L., additional, Galdieri, N., additional, Martiniello, A., additional, Monteforte, I., additional, Monda, V., additional, Tardio, M.L., additional, Leone, O., additional, Maiello, C., additional, and Scardone, M., additional
- Published
- 2013
- Full Text
- View/download PDF
4. APOPTOSIS IN MEDULLOBLASTOMA
- Author
-
Pierconti, F., primary, Rinelli, A., additional, Tardio, M.L., additional, and Lauriola, L., additional
- Published
- 1996
- Full Text
- View/download PDF
5. Evidence of enteric angiopathy and neuromuscular hypoxia in patients with mitochondrial neurogastrointestinal encephalomyopathy
- Author
-
Maria Lucia Tardio, Anna Accarino, Carla Giordano, Giovanna Cenacchi, Antonietta D'Errico, Catia Sternini, Rita Rinaldi, Vitaliano Tugnoli, Roberto De Giorgio, Loris Pironi, Valeria Righi, Giacomo Caio, Roberta Costa, Paolo Clavenzani, Maria Teresa Dotti, Valerio Carelli, Vincenzo Stanghellini, Roberto D'Angelo, Elisa Boschetti, Caterina Garone, Carolina Malagelada, Boschetti E., D'Angelo R., Tardio M.L., Costa R., Giordano C., Accarino A., Malagelada C., Clavenzani P., Tugnoli V., Caio G., Righi V., Garone C., D'Errico A., Cenacchi G., Dotti M.T., Stanghellini V., Sternini C., Pironi L., Rinaldi R., Carelli V., and De Giorgio R.
- Subjects
0301 basic medicine ,Pathology ,medicine.medical_specialty ,Submucosal vessels ,Fibrosi ,Physiology ,Angiogenesis ,Angiopathy ,NO ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Muscular Dystrophy, Oculopharyngeal ,Mitochondrial Encephalomyopathies ,Fibrosis ,Physiology (medical) ,Humans ,Medicine ,Thymidine phosphorylase ,Sirius Red ,Gastrointestinal bleeding ,Thymidine Phosphorylase ,Ophthalmoplegia ,Neovascularization, Pathologic ,Hepatology ,business.industry ,Intestinal Pseudo-Obstruction ,Microangiopathy ,Gastroenterology ,Platelet-derived endothelial cell growth factor 1 ,Hypoxia (medical) ,medicine.disease ,Pathophysiology ,Gastrointestinal Tract ,Angiogenesi ,030104 developmental biology ,chemistry ,medicine.symptom ,business ,030217 neurology & neurosurgery ,Research Article ,angiogenesis ,fibrosis ,gastrointestinal bleeding ,platelet derived endothelial cell growth factor ,submucosal vessels - Abstract
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is a rare autosomal recessive disease caused by thymidine phosphorylase (TP) enzyme defect. As gastrointestinal changes do not revert in patients undergone TP replacement therapy, one can postulate that other unexplored mechanisms contribute to MNGIE pathophysiology. Hence, we focused on the local TP angiogenic potential that has never been considered in MNGIE. In this study, we investigated the enteric submucosal microvasculature and the effect of hypoxia on fibrosis and enteric neurons density in jejunal full-thickness biopsies collected from patients with MNGIE. Orcein staining was used to count blood vessels based on their size. Fibrosis was assessed using the Sirius Red and Fast Green method. Hypoxia and neoangiogenesis were determined via hypoxia-inducible-factor-1α (HIF-1α) and vascular endothelial cell growth factor (VEGF) protein expression, respectively. Neuron-specific enolase was used to label enteric neurons. Compared with controls, patients with MNGIE showed a decreased area of vascular tissue, but a twofold increase of submucosal vessels/mm(2) with increased small size and decreased medium and large size vessels. VEGF positive vessels, fibrosis index, and HIF-1α protein expression were increased, whereas there was a diminished thickness of the longitudinal muscle layer with an increased interganglionic distance and reduced number of myenteric neurons. We demonstrated the occurrence of an angiopathy in the GI tract of patients with MNGIE. Neoangiogenetic changes, as detected by the abundance of small size vessels in the jejunal submucosa, along with hypoxia provide a morphological basis to explain neuromuscular alterations, vasculature breakdown, and ischemic abnormalities in MNGIE. NEW & NOTEWORTHY Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) is characterized by a genetically driven defect of thymidine phosphorylase, a multitask enzyme playing a role also in angiogenesis. Indeed, major gastrointestinal bleedings are life-threatening complications of MNGIE. Thus, we focused on jejunal submucosal vasculature and showed intestinal microangiopathy as a novel feature occurring in this disease. Notably, vascular changes were associated with neuromuscular abnormalities, which may explain gut dysfunction and help to develop future therapeutic approaches in MNGIE.
- Published
- 2021
6. Colonic perforation as initial presentation of amyloid disease. Case report and literature review
- Author
-
Ignazio R. Marino, Maurizio Cervellera, Vito D'Andrea, Valeria Tonini, M L Tardio, Samuele Vaccari, A. Caira, Augusto Lauro, O Leone, Alessandro Ussia, Ussia A., Vaccari S., Lauro A., Caira A., Tardio M.L., Leone O., Marino I.R., D'Andrea V., Cervellera M., and Tonini V.
- Subjects
Reoperation ,Amyloid disease ,medicine.medical_specialty ,Physiology ,Perforation (oil well) ,Constriction, Pathologic ,Disease ,Polymyositis ,Colonic Diseases ,03 medical and health sciences ,Postoperative Complications ,0302 clinical medicine ,Internal medicine ,Perforation ,Surgery ,Colostomy ,medicine ,Humans ,Colectomy ,Aged ,business.industry ,Amyloidosis ,Gastroenterology ,Surgical Stomas ,Hepatology ,Colitis ,medicine.disease ,Stenosis ,Intestinal Perforation ,030220 oncology & carcinogenesis ,Female ,030211 gastroenterology & hepatology ,Presentation (obstetrics) ,business - Abstract
Introduction: Amyloidosis is an uncommon disease caused by the deposition of amyloid fibrils in tissues. This disease does not usually require surgical intervention, which could be warranted in the presence of complications such as bleeding, obstruction, or perforation. We present a case of primary amyloidosis of the colon in a patient affected by polymyositis who underwent Hartmann’s procedure after a spontaneous colonic perforation. After 2months of well-being, the patient underwent two consecutive surgical procedures for stenosis of the ostomy orifice. Areas Covered: A review of the literature has been performed, gathering case reports highlighting the distribution of this disease by age, gender, location, and treatment when available. Expert Commentary: Gastrointestinal amyloid disease is a rare condition, and it could be considered among the rare causes of intestinal perforation. Timely surgical management is often necessary.
- Published
- 2020
7. Abdominal neoplasia with sarcomatoid features as the presenting illness of a patient with a newly diagnosed HIV infection and no AIDS-related disorders. Case report, clinical and diagnostic features, and literature discussion
- Author
-
Roberto Manfredi, Eleonora Magistrelli, Sergio Sabbatani, Maria Lucia Tardio, Manfredi R., Sabbatani S., Magistrelli E., and Tardio M.L.
- Subjects
Pediatrics ,medicine.medical_specialty ,Human immunodeficiency virus (HIV) ,Medicine (miscellaneous) ,Newly diagnosed HIV infection ,Newly diagnosed ,medicine.disease_cause ,Malignancy ,Sarcomatoid features ,Acquired immunodeficiency syndrome (AIDS) ,Case report ,medicine ,Rare solid tumors ,Differential diagnosis ,lcsh:R5-920 ,business.industry ,Cancer ,Rare solid tumor ,medicine.disease ,Abdominal mass ,Surgery ,Sarcomatoid Features ,Sarcomatoid feature ,Business, Management and Accounting (miscellaneous) ,Infectivology ,medicine.symptom ,business ,lcsh:Medicine (General) - Abstract
We aim to describe a patient with an already advanced HIV infection disclosed for the first time during a complex diagnostic workup, which detected a gross abdominal mass attributable to a poorly differentiated mesenchymal cancer with sarcomatoid features which rapidly led our patient to death, in absence of other potential HIV-associated opportunistic diseases. Although extremely rare and rapidly lethal, our case report underscores the need of all caregivers who follow HIV-infected patients also in the cART era to maintain an elevated attention toward infrequent, unexpected, and clinically atypical solid tumors, in order to ensure a timely diagnosis and management when possible.
- Published
- 2014
8. Ki-67 and p53 expression in ghost cell odontogenic carcinoma: a case report and literature review
- Author
-
Davide Bartolomeo Gissi, Claudio Marchetti, G. Del Corso, Achille Tarsitano, Maria Lucia Tardio, Lucio Montebugnoli, Del Corso, G., Tardio, M.L., Gissi, D.B., Marchetti, C., Montebugnoli, L., and Tarsitano, A.
- Subjects
Male ,Pathology ,medicine.medical_specialty ,Biopsy ,Diagnosis, Differential ,Calcifying odontogenic cyst ,Odontogenic cyst ,Radiography, Panoramic ,medicine ,Humans ,Aged, 80 and over ,Ghost Cell Odontogenic Carcinoma ,biology ,medicine.diagnostic_test ,Ghost cell carcinoma . Odontogenic carcinoma . Ghost cell tumors ,business.industry ,Ghost cell ,medicine.disease ,Odontogenic Cyst, Calcifying ,Mandibular Neoplasms ,Ki-67 Antigen ,Otorhinolaryngology ,Ki-67 ,biology.protein ,Oral and maxillofacial surgery ,Immunohistochemistry ,Surgery ,Oral Surgery ,Tumor Suppressor Protein p53 ,business - Abstract
Ghost cell odontogenic carcinomas are rare neoplasms that arise in the maxillary bones either from a calcifying odontogenic cyst or de novo. They are aggressive locally and can metastasize. We report herein a case of a ghost cell odontogenic carcinoma arising in the mandible of a Caucasian male 86 years of age. We have described the clinical and radiographic features, histological characteristics, immunohistochemistry findings, and surgical treatment. We especially focused on how Ki-67 expression guides the treatment choice. Finally, we reviewed 32 cases described in the literature and compared them with the cases described up until 2014 to help clinicians identify the diagnostic characteristics of and select appropriate treatment modalities for ghost cell odontogenic carcinomas.
- Published
- 2015
9. Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment?
- Author
-
Francesco Minni, Raffaele Lombardi, S. Pini, Ferdinando Lecce, Piergiorgio Di Tullio, Andrea Martoni, Maria Lucia Tardio, Carmine Pinto, Bruno Cola, Giampaolo Ugolini, Stefano Neri, Mario Taffurelli, Francesca Di Fabio, B. Iacopino, Claudio Ceccarelli, Dajana Cuicchi, Lombardi R., Cuicchi D., Pinto C., Di Fabio F., Iacopino B., Neri S., Tardio M.L., Ceccarelli C., Lecce F., Ugolini G., Pini S., Di Tullio P., Taffurelli M., Minni F., Martoni A., and Cola B.
- Subjects
Adult ,Male ,medicine.medical_specialty ,PROGNOSIS ,Organoplatinum Compounds ,Colorectal cancer ,medicine.medical_treatment ,Adenocarcinoma ,Preoperative care ,RECTAL CANCER ,RADIATION THERAPY ,Antineoplastic Combined Chemotherapy Protocols ,Preoperative Care ,medicine ,Combined Modality Therapy ,Humans ,Stage (cooking) ,Survival rate ,NEOADJUVANT THERAPY ,Neoadjuvant therapy ,Aged ,Aged, 80 and over ,business.industry ,Rectal Neoplasms ,Radiotherapy Dosage ,Middle Aged ,medicine.disease ,Radiation therapy ,Oxaliplatin ,Survival Rate ,NEOPLASM STAGING ,Oncology ,Surgery ,Female ,Radiology ,Fluorouracil ,business ,Chemoradiotherapy - Abstract
BACKGROUND: Preoperative chemoradiotherapy has been widely adopted as the standard of care for stage II-III rectal cancers. However, patients with T3N0 lesions had been shown to have a better prognosis than other categories of locally advanced tumor. Thus, neoadjuvant chemoradiation is likely to be overtreatment in this subgroup of patients. Nevertheless, the low accuracy rate of preoperative staging techniques for detection of node-negative tumors does not allow to check this hypothesis. We analyzed a group of patients with cT3N0 low rectal cancer who underwent neoadjuvant chemoradiotherapy with the purpose of evaluating the incidence of metastatic nodes in the resected specimens. METHODS: Between January 2002 and February 2008, 100 patients with low rectal cancer underwent clinical staging by means of endorectal ultrasound, computed tomography, positron emission tomography, and magnetic resonance imaging. All patients received preoperative 5-fluorouracil-based chemoradiotherapy and surgical resection with curative aim. RESULTS: Of 100 patients with locally advanced rectal cancer, 32 were clinically staged as T3N0M0. Pathological analysis showed the presence of lymph node metastases in nine patients (28%) (node-positive group). In the remaining 23 cases, clinical N stage was confirmed at pathology (node-negative group). Node-positive and node-negative groups differ only in the number of ypT3 tumors (P < .01). CONCLUSIONS: Our results indicate that immediate surgery for patients with cT3N0 rectal cancer represents an undertreatment risk in at least 28% of cases, making necessary the use of postoperative chemoradiotherapy. Preoperative chemoradiotherapy should be the therapy of choice on the grounds of the principle that overtreatment is less hazardous than undertreatment for cT3N0 rectal cancers.
- Published
- 2010
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.